HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-MAY-12 4FC0 TITLE CRYSTAL STRUCTURE OF HUMAN KINASE DOMAIN OF B-RAF WITH A DFG-OUT TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 445-726); COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL COMPND 6 ONCOGENE HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, P94, RAFB1, V-RAF MURINE SARCOMA VIRAL ONCOGENE SOURCE 6 HOMOLOG B1; SOURCE 7 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS HUMAN SERINE/THERONINE PROTEIN KINASE, KINASE DRUG COMPLEX, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.K.YANO,K.AERTGEERTS REVDAT 2 28-FEB-24 4FC0 1 REMARK SEQADV REVDAT 1 08-JAN-14 4FC0 0 JRNL AUTH M.HIROSE,M.OKANIWA,T.MIYAZAKI,T.IMADA,T.OHASHI,Y.TANAKA, JRNL AUTH 2 T.ARITA,M.YABUKI,T.KAWAMOTO,S.TSUTSUMI,A.SUMITA,T.TAKAGI, JRNL AUTH 3 B.C.SANG,J.YANO,K.AERTGEERTS,S.YOSHIDA,T.ISHIKAWA JRNL TITL DESIGN AND SYNTHESIS OF NOVEL DFG-OUT RAF/VASCULAR JRNL TITL 2 ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (VEGFR2) INHIBITORS: 3. JRNL TITL 3 EVALUATION OF 5-AMINO-LINKED THIAZOLO[5,4-D]PYRIMIDINE AND JRNL TITL 4 THIAZOLO[5,4-B]PYRIDINE DERIVATIVES. JRNL REF BIOORG.MED.CHEM. V. 20 5600 2012 JRNL REFN ISSN 0968-0896 JRNL PMID 22883026 JRNL DOI 10.1016/J.BMC.2012.07.032 REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.800 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 19355 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 986 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.03 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1288 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.3150 REMARK 3 BIN FREE R VALUE SET COUNT : 77 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4126 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.75000 REMARK 3 B22 (A**2) : 0.75000 REMARK 3 B33 (A**2) : -1.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.305 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.356 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.262 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 30.277 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4303 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2919 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5821 ; 1.079 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7116 ; 0.795 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 512 ; 5.519 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 185 ;36.215 ;23.730 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 769 ;17.573 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 27 ;14.704 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 633 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4687 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 841 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2567 ; 0.242 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1045 ; 0.034 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4150 ; 0.482 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1736 ; 0.748 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1665 ; 1.317 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 447 A 532 REMARK 3 ORIGIN FOR THE GROUP (A): 48.3840 -30.6630 13.5010 REMARK 3 T TENSOR REMARK 3 T11: 0.2343 T22: 0.1648 REMARK 3 T33: 0.2226 T12: 0.0357 REMARK 3 T13: -0.0286 T23: 0.0096 REMARK 3 L TENSOR REMARK 3 L11: 4.5825 L22: 3.3343 REMARK 3 L33: 6.8415 L12: -0.5454 REMARK 3 L13: -1.4207 L23: -0.2680 REMARK 3 S TENSOR REMARK 3 S11: -0.1024 S12: -0.7083 S13: 0.1013 REMARK 3 S21: 0.4790 S22: -0.0112 S23: -0.7668 REMARK 3 S31: 0.2348 S32: 0.7576 S33: 0.1136 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 533 A 721 REMARK 3 ORIGIN FOR THE GROUP (A): 43.5380 -42.9780 -9.6000 REMARK 3 T TENSOR REMARK 3 T11: 0.1652 T22: 0.2032 REMARK 3 T33: 0.0520 T12: 0.0274 REMARK 3 T13: -0.0005 T23: -0.0252 REMARK 3 L TENSOR REMARK 3 L11: 1.0853 L22: 4.2279 REMARK 3 L33: 1.9698 L12: -0.8051 REMARK 3 L13: -1.3372 L23: 0.8798 REMARK 3 S TENSOR REMARK 3 S11: 0.2172 S12: 0.2900 S13: 0.0164 REMARK 3 S21: -0.3320 S22: -0.1268 S23: 0.1223 REMARK 3 S31: -0.2539 S32: -0.1700 S33: -0.0904 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 447 B 532 REMARK 3 ORIGIN FOR THE GROUP (A): 36.0260 -11.9880 -2.7640 REMARK 3 T TENSOR REMARK 3 T11: 0.2561 T22: 0.2152 REMARK 3 T33: 0.1828 T12: 0.0728 REMARK 3 T13: 0.0451 T23: 0.0794 REMARK 3 L TENSOR REMARK 3 L11: 2.3434 L22: 5.4005 REMARK 3 L33: 6.2482 L12: -0.2855 REMARK 3 L13: -0.8576 L23: -0.2560 REMARK 3 S TENSOR REMARK 3 S11: 0.0521 S12: 0.5136 S13: 0.5460 REMARK 3 S21: -0.5072 S22: 0.0099 S23: -0.3410 REMARK 3 S31: -0.5585 S32: -0.1042 S33: -0.0620 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 533 B 719 REMARK 3 ORIGIN FOR THE GROUP (A): 20.7660 -15.4060 18.9450 REMARK 3 T TENSOR REMARK 3 T11: 0.1256 T22: 0.0787 REMARK 3 T33: 0.0350 T12: -0.0456 REMARK 3 T13: 0.0292 T23: 0.0167 REMARK 3 L TENSOR REMARK 3 L11: 4.5082 L22: 3.2299 REMARK 3 L33: 2.4075 L12: -2.0373 REMARK 3 L13: -1.5589 L23: 1.8245 REMARK 3 S TENSOR REMARK 3 S11: -0.0026 S12: 0.1944 S13: -0.0308 REMARK 3 S21: 0.1191 S22: 0.0502 S23: 0.1397 REMARK 3 S31: 0.1236 S32: -0.0414 S33: -0.0476 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES: WITH TLS ADDED REMARK 4 REMARK 4 4FC0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072711. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 92 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED SI REMARK 200 (111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19439 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.800 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.18600 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7.8% PEG 8000, 0.8M LICL, 100 MM TRIS, REMARK 280 PH 8.3, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.98650 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 54.98400 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 54.98400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.49325 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 54.98400 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 54.98400 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 109.47975 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 54.98400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.98400 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.49325 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 54.98400 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.98400 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 109.47975 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 72.98650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 442 REMARK 465 SER A 443 REMARK 465 ASP A 444 REMARK 465 SER A 445 REMARK 465 SER A 446 REMARK 465 LEU A 596 REMARK 465 ALA A 597 REMARK 465 THR A 598 REMARK 465 VAL A 599 REMARK 465 LYS A 600 REMARK 465 SER A 601 REMARK 465 ARG A 602 REMARK 465 TRP A 603 REMARK 465 SER A 604 REMARK 465 GLY A 605 REMARK 465 SER A 606 REMARK 465 HIS A 607 REMARK 465 GLN A 608 REMARK 465 PHE A 609 REMARK 465 GLU A 610 REMARK 465 GLN A 611 REMARK 465 LEU A 612 REMARK 465 SER A 613 REMARK 465 GLN A 627 REMARK 465 ASP A 628 REMARK 465 LYS A 629 REMARK 465 LYS A 722 REMARK 465 ILE A 723 REMARK 465 HIS A 724 REMARK 465 ARG A 725 REMARK 465 GLY B 442 REMARK 465 SER B 443 REMARK 465 ASP B 444 REMARK 465 SER B 445 REMARK 465 SER B 446 REMARK 465 SER B 604 REMARK 465 GLY B 605 REMARK 465 SER B 606 REMARK 465 HIS B 607 REMARK 465 GLN B 608 REMARK 465 PHE B 609 REMARK 465 GLU B 610 REMARK 465 GLN B 611 REMARK 465 LEU B 612 REMARK 465 SER B 613 REMARK 465 LEU B 720 REMARK 465 PRO B 721 REMARK 465 LYS B 722 REMARK 465 ILE B 723 REMARK 465 HIS B 724 REMARK 465 ARG B 725 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 467 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 521 CG CD CE NZ REMARK 470 LYS B 521 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 700 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 466 -83.39 51.81 REMARK 500 ASN A 485 -80.95 -65.73 REMARK 500 ALA A 488 71.97 -108.85 REMARK 500 ILE A 542 -67.26 -96.02 REMARK 500 ARG A 574 -12.64 80.25 REMARK 500 ASP A 575 45.14 -152.42 REMARK 500 LEU A 587 -51.67 -149.85 REMARK 500 SER A 615 65.51 -107.59 REMARK 500 ARG A 625 46.40 -106.21 REMARK 500 LEU A 720 -63.19 -178.25 REMARK 500 ASN B 485 11.38 -66.41 REMARK 500 GLN B 523 132.12 -177.01 REMARK 500 ILE B 542 -70.50 -116.83 REMARK 500 ASP B 575 38.11 -156.75 REMARK 500 GLU B 585 17.55 57.49 REMARK 500 LEU B 587 -2.21 -149.46 REMARK 500 PHE B 594 51.36 -95.71 REMARK 500 LEU B 596 -8.23 75.63 REMARK 500 ARG B 700 -60.42 -29.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0T2 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0T2 B 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3Q96 RELATED DB: PDB REMARK 900 RELATED ID: 4DBN RELATED DB: PDB DBREF 4FC0 A 444 725 UNP P15056 BRAF_HUMAN 445 726 DBREF 4FC0 B 444 725 UNP P15056 BRAF_HUMAN 445 726 SEQADV 4FC0 GLY A 442 UNP P15056 EXPRESSION TAG SEQADV 4FC0 SER A 443 UNP P15056 EXPRESSION TAG SEQADV 4FC0 GLY B 442 UNP P15056 EXPRESSION TAG SEQADV 4FC0 SER B 443 UNP P15056 EXPRESSION TAG SEQRES 1 A 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 A 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 A 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 A 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 A 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 A 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 A 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 A 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 A 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 A 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 A 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 A 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 A 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 A 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 A 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 A 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 A 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 A 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 A 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 A 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 A 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 A 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG SEQRES 1 B 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 B 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 B 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 B 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 B 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 B 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 B 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 B 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 B 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 B 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 B 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 B 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 B 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 B 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 B 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 B 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 B 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 B 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 B 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 B 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 B 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 B 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG HET 0T2 A 901 40 HET 0T2 B 901 40 HETNAM 0T2 2-CHLORO-3-[(2-CYANOPROPAN-2-YL)OXY]-N-{5-[{2- HETNAM 2 0T2 [(CYCLOPROPYLCARBONYL)AMINO][1,3]THIAZOLO[5,4- HETNAM 3 0T2 B]PYRIDIN-5-YL}(METHYL)AMINO]-2-FLUOROPHENYL}BENZAMIDE FORMUL 3 0T2 2(C28 H24 CL F N6 O3 S) FORMUL 5 HOH *160(H2 O) HELIX 1 1 THR A 490 ARG A 505 1 16 HELIX 2 2 LEU A 536 ILE A 542 1 7 HELIX 3 3 GLU A 548 LYS A 569 1 22 HELIX 4 4 LYS A 577 ASN A 579 5 3 HELIX 5 5 SER A 615 MET A 619 5 5 HELIX 6 6 ALA A 620 ARG A 625 1 6 HELIX 7 7 SER A 633 GLY A 651 1 19 HELIX 8 8 ASN A 660 ARG A 670 1 11 HELIX 9 9 ASP A 676 VAL A 680 5 5 HELIX 10 10 PRO A 685 LEU A 696 1 12 HELIX 11 11 LYS A 699 ARG A 703 5 5 HELIX 12 12 LEU A 705 SER A 719 1 15 HELIX 13 13 THR B 490 ARG B 505 1 16 HELIX 14 14 LEU B 536 ILE B 542 1 7 HELIX 15 15 GLU B 548 LYS B 569 1 22 HELIX 16 16 LYS B 577 ASN B 579 5 3 HELIX 17 17 SER B 615 MET B 619 5 5 HELIX 18 18 ALA B 620 MET B 626 1 7 HELIX 19 19 SER B 633 GLY B 651 1 19 HELIX 20 20 ASN B 660 ARG B 670 1 11 HELIX 21 21 ASP B 676 VAL B 680 5 5 HELIX 22 22 PRO B 685 LEU B 696 1 12 HELIX 23 23 LYS B 699 ARG B 703 5 5 HELIX 24 24 LEU B 705 ARG B 718 1 14 SHEET 1 A 5 THR A 457 GLY A 465 0 SHEET 2 A 5 GLY A 468 LYS A 474 -1 O VAL A 470 N GLY A 463 SHEET 3 A 5 ASP A 478 LEU A 484 -1 O MET A 483 N THR A 469 SHEET 4 A 5 ALA A 525 GLN A 529 -1 O ILE A 526 N LYS A 482 SHEET 5 A 5 PHE A 515 SER A 519 -1 N GLY A 517 O VAL A 527 SHEET 1 B 3 GLY A 533 SER A 535 0 SHEET 2 B 3 ILE A 581 HIS A 584 -1 O LEU A 583 N SER A 534 SHEET 3 B 3 THR A 588 ILE A 591 -1 O THR A 588 N HIS A 584 SHEET 1 C 5 THR B 457 GLY B 465 0 SHEET 2 C 5 GLY B 468 LYS B 474 -1 O GLY B 468 N GLY B 465 SHEET 3 C 5 ASP B 478 MET B 483 -1 O VAL B 479 N GLY B 473 SHEET 4 C 5 ALA B 525 GLN B 529 -1 O ILE B 526 N LYS B 482 SHEET 5 C 5 PHE B 515 SER B 519 -1 N GLY B 517 O VAL B 527 SHEET 1 D 3 GLY B 533 SER B 535 0 SHEET 2 D 3 ILE B 581 HIS B 584 -1 O LEU B 583 N SER B 534 SHEET 3 D 3 THR B 588 ILE B 591 -1 O LYS B 590 N PHE B 582 CISPEP 1 LYS A 521 PRO A 522 0 0.79 SITE 1 AC1 17 ALA A 480 LYS A 482 GLU A 500 VAL A 503 SITE 2 AC1 17 LEU A 504 LEU A 513 ILE A 526 THR A 528 SITE 3 AC1 17 GLN A 529 TRP A 530 CYS A 531 GLY A 533 SITE 4 AC1 17 ILE A 591 GLY A 592 ASP A 593 PHE A 594 SITE 5 AC1 17 HOH A1034 SITE 1 AC2 20 VAL B 470 ALA B 480 LYS B 482 GLU B 500 SITE 2 AC2 20 VAL B 503 LEU B 504 LEU B 513 ILE B 526 SITE 3 AC2 20 THR B 528 GLN B 529 TRP B 530 CYS B 531 SITE 4 AC2 20 GLY B 533 LEU B 566 HIS B 573 PHE B 582 SITE 5 AC2 20 GLY B 592 ASP B 593 PHE B 594 ALA B 597 CRYST1 109.968 109.968 145.973 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009094 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009094 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006851 0.00000